NYSE:ENOVMedical Equipment
Enovis (ENOV) FY 2025 Loss Of US$9.07 EPS Tests Margin Turnaround Narrative
Enovis (ENOV) has wrapped up FY 2025 with fourth quarter revenue of US$575.8 million and a basic EPS loss of US$9.07, alongside trailing twelve month revenue of about US$2.2 billion and a cumulative EPS loss of US$20.72. Over the past six reported quarters, revenue has moved from US$505.2 million in Q3 2024 to US$575.8 million in Q4 2025, while basic EPS has ranged from a loss of US$0.61 to a loss of US$12.06 as the business absorbed sizeable charges and ongoing losses. That mix of solid top...